Background/Purpose: Previous FDG-PET studies have indicated neuroplasticity in the adult auditory cortex in cases of postlingual deafness. In the mature brain, auditory deprivation decreased neuronal activity in primary auditory and auditory-related cortices. In order to reevaluate these issues, we used statistical analytic software, namely a three-dimensional stereotaxic region of interest template (3DSRT), in addition to statistical parametric mapping (SPM; Institute of Neurology, University College of London, UK). MaterialsandMethods:18F-FDG brain PET scans were performed on 7 postlingually deaf patients and 10 healthy volunteers. Significant increases and decreases of regional cerebral glucose metabolism in the patient group were estimated by comparing their PET images with those of healthy volunteers using SPM analysis and 3DSRT. Results: SPM revealed that the glucose metabolism of the deaf patients was lower in the right superior temporal gyrus, both middle temporal gyri, left inferior temporal gyrus, right inferior lobulus parietalis, right posterior cingulate gyrus, and left insular cortex than that of the control subjects. 3DSRT data also revealed significantly decreased glucose metabolism in both primary auditory cortices of the postlingually deaf patients. Conclusion: SPM and 3DSRT analyses indicated that glucose metabolism decreased in the primary auditory cortex of the postlingually deaf patients. The previous results of PET studies were confirmed, and our method involving 3DSRT has proved to be useful.

1.
Ito J, Sakakibara J, Iwasaki Y, Yonekura Y: Positron emission computed tomography of auditory sensation in deaf patients and patients with cochlear implants. Ann Otol Rhinol Laryngol 1993;102:797-801.
2.
Lee JS, Lee DS, Oh SH, Kim CS, Kim JW, Hwang CH, Koo J, Kang E, Chung JK, Lee MC: PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med 2003;44:1435-1439.
3.
Takeuchi R, Sengoku T, Matsumura K: Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 2006;24:538-544.
4.
Tateno M, Utsumi K, Kobayashi S, Takahashi A, Saitoh M, Morii H, Fujii K, Teraoka M: Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1206-1209.
5.
Kataoka K, Hashimoto H, Kawabe J, Higashiyama S, Akiyama H, Shimada A, Kai T, Inoue K, Shiomi S, Kiriike N: Frontal hypoperfusion in depressed patients with dementia of Alzheimer type demonstrated on 3DSRT. Psychiatry Clin Neurosci 2010;64:293-298.
6.
Torigai T, Mase M, Ohno T, Katano H, Nisikawa Y, Sakurai K, Sasaki S, Toyama J, Yamada K: Usefulness of dual and fully automated measurements of cerebral blood flow during balloon occlusion test of the internal carotid artery. J Stroke Cerebrovasc Dis 2011;17:1-8.
7.
Marushima A, Tsurushima H, Suzuki K, Nakai Y, Nemoto H, Matsumura A: Time-course analysis of brain perfusion single photon emission computed tomography using a three dimensional stereotactic region-of-interest template in patients with moyamoya disease. World Neurosurg 2011;76:304-310.
8.
Rauschecker JP: Auditory cortical plasticity: a comparison with other sensory systems. Trends Neurosci 1999;22:74-80.
9.
Lee DS, Lee JS, Oh SH, Kim SK, Kim JW, Chung JK, Lee MC, Kim CS: Cross-modal plasticity and cochlear implants. Nature 2001;409:149-150.
10.
Ahn SH, Oh SH, Lee JS, Jeong JM, Lim D, Lee DS, Kim CS: Changes of 2-deoxyglucose uptake in the rat auditory pathway after bilateral ablation of the cochlea. Hear Res 2004;196:33-38.
11.
Fujiwara K, Naito Y, Senda M, Mori T, Manabe T, Shinohara S, Kikuchi M, Hori SY, Tona Y, Yamazaki H: Brain metabolism of children with profound deafness: a visual language activation study by 18F-fluorodeoxyglucose positron emission tomography. Acta Otolaryngol 2008;128:393-397.
12.
Moteki H, Naito Y, Fujiwara K, Kitoh R, Nishio SY, Oguchi K, Takumi Y, Usami S: Different cortical metabolic activation by visual stimuli possibly due to different time courses of hearing loss in patients with GJB2 and SLC26A4 mutations. Acta Otolaryngol 2011;131:1232-1236.
13.
Levänen S, Jousmäki V, Hari R: Vibration-induced auditory-cortex activation in a congenitally deaf adult. Curr Biol 1998;8:869-872.
14.
Sadato N, Okada T, Honda M, Matsuki K, Yoshida M, Kashikura K, Takei W, Sato T, Kochiyama T, Yonekura Y: Cross-modal integration and plastic changes revealed by lip movement, random-dot motion and sign languages in the hearing and deaf. Cereb Cortex 2005;15:1113-1122.
15.
Park MH, Lee HJ, Kim JS, Lee JS, Lee DS, Oh SH: Cross-modal and compensatory plasticity in adult deafened cats: a longitudinal PET study. Brain Res 2010;1354:85-90.
16.
Schwartzman A, Dougherty RF, Lee J, Ghahremani D, Taylor JE: Empirical null and false discovery rate analysis in neuroimaging. Neuroimage 2009;44:71-82.
17.
Lawson RS: Application of mathematical methods in dynamic nuclear medicine studies. Phys Med Biol 1999;44:R57-R98.
18.
Person C, Louis-Dorr V, Poussier S, Commowick O, Malandain G, Maillard L, Wolf D, Gillet N, Roch V, Karcher G, Marie PY: Voxel-based quantitative analysis of brain images from 18F-FDG PET with a block-matching algorithm for spatial normalization. Clin Nucl Med 2012;37:268-273.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.